913358-93-7Relevant articles and documents
CRYSTALLINE AND AMORPHOUS FORMS OF ALMOREXANT AND A METHOD OF THEIR PREPARATION
-
Page/Page column 5-6, (2011/06/23)
The invention relates to crystalline and amorphous forms of (2R)-2-{(1S)-6,7-dimethoxy-1-[2-(4-trifluoromethyl-phenyl)-ethyl] -3,4-dihydro- 1H-isoquinolin-2-yl} -N-methyl-2-phenyl- acetamide hydrochloride (I) (almorexant) and a method of their preparation
TRISUBSTITUTED 3,4-DIHYDRO-1H-ISOQUINOLIN COMPOUND, PROCESS FOR ITS PREPARATION, AND ITS USE
-
Page/Page column 13-14, (2010/02/17)
The present invention relates to the compound of formula 7*acetate (see below), a process for its preparation, and its use
PROCESS FOR THE PREPARATION OF AN ENANTIOMERIC TRISUBSTITUTED 3,4-DIHYDRO-ISOQUINOLINE DERIVATIVE
-
Page/Page column 29, (2009/08/14)
The present invention relates to a process for the preparation of the compound of formula (7) which process comprises the hydrogenation of the compound of formula (4) using bis[chloro-1,5-cyclooctadiene-iridium], (S)-i -dicyclohexylphosphino- 2-[(S)-α-(di